|
|
Exchange: |
N/A |
Security
Type: |
Common |
Shares
Out: |
82,270,000 |
Market
Cap: |
232.00(M) |
Last
Volume: |
0 |
Avg
Vol: |
0 |
52
Week Range: |
$2.67 - $29.36 |
|
Level
I Sector: |
N/A |
Level
II Sector: |
N/A |
Level
III Sector: |
N/A |
|
Member Indexes:
|
Rankings:
|
Insider 3 Months : - |
Insider 6 Months : 8.1 |
Insider 3/6 Months : 8.7 |
|
Guru Rank Number : - |
Guru Rank Value : - |
Guru Occurances : - |
|
|
|
|
|
|
|
Company Profile Revance Therapeutics is a biotechnology company focused on aesthetic and therapeutic offerings, including its neuromodulator product, DaxibotulinumtoxinA for Injection. Co.'s segments are: Product, which refers to the business that includes the research, development and commercialization of its product candidates and the RHA® Collection of dermal fillers; and Service, which refers to the business that includes the development and commercialization of the OPUL Relational Commerce Platform and HintMD platform.
|
|
D/I:
|
|
|
D
is for direct shares.
I is
for indirect shares.
D/I
refers to the Direct or Indirect
shares traded vs. held. |
|
|
Forms:
|
|
|
A
Form 4 is a form filed
by an insider to indicate a change
in ownership.
A Form
3 is a form filed by
an insider to indicate an
initial ownership of a security. |
|
|
3m +/-:
|
|
|
This
represents the company's 3 month
price change. The initial price
is based on the closing price
of the stock on the day the transaction
took place. Purchases & sales
are viewed as long & short
positions respectively.
|
|
|
Actions:
|
|
|
B |
Buy |
S |
Sell |
OE |
Option
Exercised |
A |
Acquired |
D |
Disposed |
AB |
Automatic
Buy |
AS |
Automatic
Sell |
IO |
Initial
Ownership |
|
|
|
Download:
|
|
|
Download only Transactions
Forms. (Default)
Download
only Summary Infomation.
Download
both Transactions and Summary Data
|
|
|
|
|
|
|
Summary (Direct Transactions Only) |
3 Months |
6 Months |
12 Months |
24 Months |
Total Shares Bought |
0 |
30,000 |
30,000 |
30,000 |
Total Buy Value |
$0 |
$209,400 |
$209,400 |
$209,400 |
Total People Bought |
0 |
1 |
1 |
1 |
Total Buy Transactions |
0 |
1 |
1 |
1 |
Total Shares Sold |
29,089 |
29,089 |
118,201 |
446,160 |
Total Sell Value |
$143,717 |
$143,717 |
$2,047,418 |
$12,719,522 |
Total People Sold |
4 |
4 |
5 |
5 |
Total Sell Transactions |
4 |
4 |
9 |
27 |
End Date |
2024-03-17 |
2023-12-15 |
2023-06-16 |
2022-06-16 |
|
Filer's Name |
Relation Title |
Off-Dir-10% |
Tran. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
3m +/- |
|
|
Form |
Moxie Dwight |
SVP, GC & Secretary |
|
2023-05-15 |
4 |
S |
$34.55 |
$739,338 |
D/D |
(21,401) |
69,165 |
|
62% |
|
Schilke Tobin |
CFO |
|
2023-05-15 |
4 |
S |
$34.55 |
$739,338 |
D/D |
(21,401) |
84,029 |
|
62% |
|
Russell Angus C. |
Director |
|
2023-05-03 |
4 |
A |
$0.00 |
$0 |
D/D |
3,534 |
36,506 |
|
- |
|
Gangolli Julian S |
Director |
|
2023-05-03 |
4 |
A |
$0.00 |
$0 |
D/D |
3,534 |
30,106 |
|
- |
|
Coric Vlad |
Director |
|
2023-05-03 |
4 |
A |
$0.00 |
$0 |
D/D |
589 |
5,784 |
|
- |
|
Kolaja Carey Oconnor |
Director |
|
2023-05-03 |
4 |
A |
$0.00 |
$0 |
D/D |
3,534 |
16,561 |
|
- |
|
Ware Olivia C |
Director |
|
2023-05-03 |
4 |
A |
$0.00 |
$0 |
D/D |
3,534 |
16,675 |
|
- |
|
Beraud Jill |
Director |
|
2023-05-03 |
4 |
A |
$0.00 |
$0 |
D/D |
3,534 |
28,606 |
|
- |
|
Nolet Chris |
Director |
|
2023-05-03 |
4 |
A |
$0.00 |
$0 |
D/D |
3,534 |
28,606 |
|
- |
|
Schilke Tobin |
CFO |
|
2023-05-01 |
4 |
AS |
$31.70 |
$101,472 |
D/D |
(3,201) |
63,081 |
|
-52% |
|
Schilke Tobin |
CFO |
|
2023-03-15 |
4 |
D |
$30.65 |
$114,600 |
D/D |
(3,739) |
69,483 |
|
- |
|
Sjuts Dustin S |
President |
|
2023-03-15 |
4 |
D |
$30.65 |
$90,939 |
D/D |
(2,967) |
120,967 |
|
- |
|
Foley Mark J |
CEO |
|
2023-03-15 |
4 |
D |
$30.65 |
$163,702 |
D/D |
(5,341) |
818,010 |
|
- |
|
Moxie Dwight |
SVP, GC & Secretary |
|
2023-03-15 |
4 |
D |
$30.65 |
$224,665 |
D/D |
(7,330) |
48,217 |
|
- |
|
Foley Mark J |
CEO |
|
2023-03-09 |
4 |
S |
$31.59 |
$2,223,360 |
D/D |
(70,390) |
823,351 |
|
26% |
|
Sjuts Dustin S |
President |
|
2023-03-09 |
4 |
S |
$31.59 |
$679,358 |
D/D |
(21,508) |
123,934 |
|
26% |
|
Moxie Dwight |
SVP, GC & Secretary |
|
2023-03-09 |
4 |
S |
$31.59 |
$584,220 |
D/D |
(18,496) |
55,547 |
|
26% |
|
Schilke Tobin |
CFO |
|
2023-03-09 |
4 |
S |
$31.59 |
$584,884 |
D/D |
(18,517) |
73,222 |
|
26% |
|
Coric Vlad |
Director |
|
2023-03-01 |
4 |
A |
$0.00 |
$0 |
D/D |
5,195 |
5,195 |
|
- |
|
Schilke Tobin |
CFO |
|
2023-03-01 |
4 |
AS |
$33.50 |
$107,234 |
D/D |
(3,201) |
49,390 |
|
-24% |
|
Sjuts Dustin S |
President |
|
2023-02-15 |
4 |
D |
$33.21 |
$91,859 |
D/D |
(2,766) |
93,046 |
|
- |
|
Schilke Tobin |
CFO |
|
2023-02-15 |
4 |
D |
$33.21 |
$69,243 |
D/D |
(2,085) |
52,591 |
|
- |
|
Schilke Tobin |
CFO |
|
2023-02-01 |
4 |
AS |
$34.60 |
$110,755 |
D/D |
(3,201) |
54,676 |
|
-14% |
|
Schilke Tobin |
CFO |
|
2023-01-20 |
4 |
AS |
$31.00 |
$31,000 |
D/D |
(1,000) |
57,877 |
|
-4% |
|
Schilke Tobin |
CFO |
|
2023-01-09 |
4 |
AS |
$25.00 |
$100,525 |
D/D |
(3,701) |
58,877 |
|
5% |
|
404 Records found
|
|
Page 3 of 17 |
|
|
|
Transaction Code Key: |
Ownership Code Key |
|
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
|
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
|
OE |
- Options Exercised |
A |
- Acquired |
|
IO |
- Initital Ownership |
D |
- Disposed |
|
|
|
|
|
|